2937-LB: Agreement of Continuous Glucose Monitoring during Oral Glucose and Mixed-Meal Tests
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-2937-lb ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von NATHAN GRANT SALA und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction and Objective: Continuous Glucose Monitoring (CGM) is widely used for glycemic management in type 2 diabetes and increasingly used in persons at risk for diabetes. CGM-derived glucose estimates may differ by up to 15% from venous plasma glucose, and performance in youth-onset type 2 diabetes (Y-T2DM), particularly during rapid glucose excursions, is not well characterized. We evaluated agreement between CGM and plasma glucose-derived metrics during an oral glucose tolerance test (OGTT) and mixed meal test (MMT) using glucose area under the curve (AUC) and model-derived disposition index without insulin (mDI-woI).
Methods
This interim analysis included 24 Y-T2DM and 9 healthy controls who underwent a 120-minute 75g OGTT and 300-minute liquid MMT. CGM (Dexcom G7) was worn during testing. Glucose AUC was calculated using the trapezoidal rule. mDI-woI, an integrated measure of β-cell function, was derived by fitting OGTT data to an insulin sensitivity and secretion model in MATLAB. Statistical analyses included Welch’s t-test, Bland-Altman analysis and Lin’s Concordance Correlation Coefficient in R.
Results
Participants were 20±3 years old (mean±SD), 52% female, BMI 36.3±11.0 kg/m2, and HbA1c 6.8±2.5%. Y-T2DM had higher BMI and HbA1c than controls (P<0.05). CGM AUC exceeded plasma AUC during OGTT (mean [95% CI] bias 2446 [1017, 3875] mg/dL·120 min, P<0.01) and MMT (3524 [1073, 5974] mg/dL·300 min, P<0.01). AUC bias did not differ between Y-T2D and controls for OGTT and MMT (P>0.05). Concordance between CGM and plasma AUC was lower for OGTT (r=0.78) than MMT (r=0.93). mDI-woI estimates were lower using CGM versus plasma glucose (bias: -0.19 [-0.27, -0.10] 10-4 mL/mU/min) with poor concordance (r=0.46).
Conclusion
During standardized metabolic testing, CGM-derived metrics overestimated glucose relative to plasma. Concordance varied by physiological context and was lower for OGTT-derived measures than MMT. Poor agreement highlights important limitations of CGM-derived metrics for modeling glucose dynamics and diabetes risk in youth. Disclosure N. Sala: None. M.M. Gaydos: None. I.N. Kacker: None. N.A. Macheret: None. S.L. Cantor: None. A. Sherman: None. J. Ha: None. N. Rangos: None. L. Mabundo: None. N. Malandrino: None. S. Chung: None. Funding National Institute of Diabetes & Digestive & Kidney Diseases, Z99 DK 999999
Zitieren
APA
SALA, N. G., GAYDOS, M. M., KACKER, I. N., MACHERET, N. A., CANTOR, S. L., SHERMAN, A., HA, J., RANGOS, N., MABUNDO, L., MALANDRINO, N., & CHUNG, S. (2026). 2937-LB: Agreement of Continuous Glucose Monitoring during Oral Glucose and Mixed-Meal Tests. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2937-lb
Vancouver
SALA NG, GAYDOS MM, KACKER IN, MACHERET NA, CANTOR SL, SHERMAN A, et al. 2937-LB: Agreement of Continuous Glucose Monitoring during Oral Glucose and Mixed-Meal Tests. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2937-lb
BibTeX
@article{SALA2026,
author = {SALA, NATHAN GRANT and GAYDOS, MADILYN M. and KACKER, ILA N. and MACHERET, NATALIE A. and CANTOR, SAMSON L. and SHERMAN, ARTHUR and HA, JOON and RANGOS, NICOLE and MABUNDO, LILIAN and MALANDRINO, NOEMI and CHUNG, STEPHANIE},
title = {2937-LB: Agreement of Continuous Glucose Monitoring during Oral Glucose and Mixed-Meal Tests},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-2937-lb}
}
EUVIMED